Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Cancers of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Testing effectiveness (Phase 2)Study completedNCT00358930
What this trial is testing

ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Large-scale testing (Phase 3)Study completedNCT05523323
What this trial is testing

Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 112
Testing effectiveness (Phase 2)Study completedNCT00503997
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT07633613
What this trial is testing

Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)Metastatic Head and Neck Squamous Cell Carcinoma
Centre Antoine Lacassagne 110
Testing effectiveness (Phase 2)Study completedNCT03162224
What this trial is testing

Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHuman Papilloma Virus
MedImmune LLC 35
Testing effectiveness (Phase 2)Looking for participantsNCT05283226
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Who this might be right for
CarcinomaRecurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
NATCO Pharma Ltd. 21
Large-scale testing (Phase 3)Looking for participantsNCT06030440
What this trial is testing

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Hypopharynx+1 more
University of Erlangen-Nürnberg Medical School 508
Early research (Phase 1)Ended earlyNCT04144140
What this trial is testing

Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

Who this might be right for
LymphomaAdvanced Solid Tumors
Eisai Inc. 24
Not applicableUnknownNCT02126189
What this trial is testing

The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study

Who this might be right for
Head and Neck Squamous Cell CarcinomaHuman Papillomavirus
Queensland Centre of Excellence for Head and Neck Cancer 600
Not applicableLooking for participantsNCT06947668
What this trial is testing

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Who this might be right for
Squamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of the HypopharynxLarynx Squamous Cell Carcinoma+1 more
University of Erlangen-Nürnberg Medical School 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05343325
What this trial is testing

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University 25
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Not applicableStudy completedNCT00160095
What this trial is testing

Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas

Who this might be right for
Larynx Cancer
Radboud University Medical Center 79
Early research (Phase 1)WithdrawnNCT01491139
What this trial is testing

Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
University College, London
Testing effectiveness (Phase 2)UnknownNCT01391572
What this trial is testing

A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 300
Early research (Phase 1)Study completedNCT01758731
What this trial is testing

Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Colorado, Denver 17
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Next Page